Evaluating patients on immune checkpoint inhibitors for cardiac adverse events: The EPICC study
Journal of Oncology Pharmacy Practice
Published online on June 24, 2025
Abstract
Journal of Oncology Pharmacy Practice, Ahead of Print.
IntroductionImmune checkpoint inhibitors (CPIs) work by engaging the patient's immune system against tumor cells and have demonstrated a significant benefit in the treatment of cancers. Activation of the patient's immune system can lead to immune-related ...
IntroductionImmune checkpoint inhibitors (CPIs) work by engaging the patient's immune system against tumor cells and have demonstrated a significant benefit in the treatment of cancers. Activation of the patient's immune system can lead to immune-related ...